Stocks · US
ELAN
XNYS
Elanco Animal Health Incorporated Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B1.71x
P/S2.24x
EPS$-0.40
ROE-3.02%
ROA-1.47%
Dividend yield0.00%
EV/EBITDA14.31x
Debt/Equity0.59
Free cash flow$379M
Returns and 52-week range
1W-0.57%
1M-8.24%
3M-8.95%
6M-1.40%
1Y+8.91%
YTD-0.18%
52W high$27.98
52W low$19.40
From 52W high-19.66%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Bio-Techne Corp. | $11.4B | 62.59 | 5.40 | +0.00% |
| BioMarin Pharmaceuticals Inc | $11.1B | 152.64 | 1.76 | -15.50% |
| DaVita Inc. | $11.4B | 13.45 | — | -1.95% |
| 이뮤니티바이오 | $11.0B | — | — | +19.93% |
| Madrigal Pharmaceuticals, Inc. Common Stock | $11.4B | — | 21.78 | -8.25% |
| Vaxcyte, Inc. Common Stock | $11.0B | — | 3.98 | +9.06% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.